H
Helen Baldomero
Researcher at University Hospital of Basel
Publications - 104
Citations - 5983
Helen Baldomero is an academic researcher from University Hospital of Basel. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 36, co-authored 94 publications receiving 5096 citations. Previous affiliations of Helen Baldomero include University of Basel.
Papers
More filters
Journal ArticleDOI
Hematopoietic stem cell transplantation: a global perspective
Alois Gratwohl,Helen Baldomero,Mahmoud Aljurf,Marcelo C. Pasquini,Luis Fernando Bouzas,Ayami Yoshimi,Jeff Szer,Jeffrey H. Lipton,Alvin Schwendener,Michael Gratwohl,Karl Frauendorfer,Dietger Niederwieser,Mary M. Horowitz,Yoshihisa Kodera,Marrow Transplantation +14 more
TL;DR: Hematopoietic stem cell transplantation is used for a broad spectrum of indications worldwide, but most frequently in countries with higher gross national incomes, higher governmental health care expenditures, and higher team densities.
Journal ArticleDOI
Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.
Alois Gratwohl,Martin Stern,Ronald Brand,Jane F. Apperley,Helen Baldomero,Theo de Witte,Giorgio Dini,Vanderson Rocha,Jakob Passweg,Anna Sureda,André Tichelli,Dietger Niederwieser,Marrow Transplantation +12 more
TL;DR: The European Group for Blood and Marrow Transplantation risk score, previously established for chronic myeloid leukemia, could be used to predict outcome after allogeneic hematopoietic stem cell transplantation for hematological disease in general.
Journal ArticleDOI
One million haemopoietic stem-cell transplants: a retrospective observational study
Alois Gratwohl,Marcelo C. Pasquini,Mahmoud Aljurf,Yoshiko Atsuta,Helen Baldomero,Lydia Foeken,Michael Gratwohl,Luis Fernando Bouzas,Dennis L. Confer,Karl Frauendorfer,Eliane Gluckman,Hildegard Greinix,Mary M. Horowitz,Minako Iida,Jeffrey H. Lipton,Alejandro Madrigal,Mohamad Mohty,Luc Noel,Nicolas Novitzky,José R. Nuñez,Machteld Oudshoorn,Jakob Passweg,Jon J. van Rood,Jeff Szer,Karl G. Blume,Frederic R Appelbaum,Yoshihisa Kodera,Dietger Niederwieser +27 more
TL;DR: The findings show achievements and high unmet needs and give guidance for decisions to grant access for patients, to provide a donor infrastructure, and to limit overuse by defining risk and region adapted indications for HSCT as an efficient and cost-effective approach for life-threatening, potentially curable diseases.
Journal ArticleDOI
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually
Jakob Passweg,Helen Baldomero,Peter Bader,Chiara Bonini,Simone Cesaro,Peter Dreger,R. F. Duarte,Carlo Dufour,Jürgen Kuball,D Farge-Bancel,Andrew R. Gennery,Kröger N,Francesco Lanza,Arnon Nagler,Anna Sureda,Mohamad Mohty +15 more
TL;DR: Trends include: continued growth in transplant activity, more so in Eastern European countries than in the west; a continued increase in the use of haploidentical family donors (by 25%) and slower growth for unrelated donor HSCT; and more autologous HSCT for plasma cell disorders and in particular for amyloidosis.
Journal ArticleDOI
Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report
Jakob Passweg,Helen Baldomero,Peter Bader,Chiara Bonini,R. F. Duarte,Carlo Dufour,Andrew R. Gennery,Kröger N,Jürgen Kuball,Francesco Lanza,Silvia Montoto,Arnon Nagler,John A. Snowden,Jan Styczyński,Mohamad Mohty +14 more
TL;DR: Use of haploidentical donors for allogeneic HSCT continues to grow: 2012 in 2015, a 291% increase since 2005, and growth is seen for all diseases.